Quiapo, Rachael Danielle .

HRN: 29-17-30  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2026
CEFUROXIME 750MG (VIAL)
06/18/2026
06/25/2026
IV
300mg
Q8
PCAP C
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  PneumoniaBloodstreamProphylaxis    Compliance to guidelines: